Baxter Hlthcare Corp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAXTER HLTHCARE CORP, and what generic alternatives to BAXTER HLTHCARE CORP drugs are available?
BAXTER HLTHCARE CORP has sixty-eight approved drugs.
There are twenty-one US patents protecting BAXTER HLTHCARE CORP drugs. There is one tentative approval on BAXTER HLTHCARE CORP drugs.
There are eleven patent family members on BAXTER HLTHCARE CORP drugs in seven countries and one hundred and thirty-seven supplementary protection certificates in fifteen countries.
Summary for Baxter Hlthcare Corp
| International Patents: | 11 |
| US Patents: | 21 |
| Tradenames: | 80 |
| Ingredients: | 54 |
| NDAs: | 68 |
Drugs and US Patents for Baxter Hlthcare Corp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | KETOROLAC TROMETHAMINE | ketorolac tromethamine | INJECTABLE;INJECTION | 209900-002 | Jul 25, 2018 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Baxter Hlthcare Corp | ACETAMINOPHEN | acetaminophen | SOLUTION;INTRAVENOUS | 214331-001 | Sep 17, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Baxter Hlthcare Corp | MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 211965-001 | Aug 11, 2020 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Baxter Hlthcare Corp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750-003 | Feb 24, 1998 | 6,207,661 | ⤷ Subscribe |
| Baxter Hlthcare Corp | ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750-002 | Feb 24, 1998 | 8,133,883 | ⤷ Subscribe |
| Baxter Hlthcare Corp | ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750-002 | Feb 24, 1998 | 6,900,184 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Baxter Hlthcare Corp Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 115243675 | ⤷ Subscribe |
| Canada | 3170514 | ⤷ Subscribe |
| Australia | 2021233893 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Baxter Hlthcare Corp Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1087960 | 1190021-4 | Sweden | ⤷ Subscribe | PRODUCT NAME: ERIBULIN OCH FARMACEUTISKT ACCEPTABLA SALTER DAERAV, I SYNNERHET ERIBULINMESYLAT; REG:NO:/DATE: EG EU/1/11/678/001-002, 2011-03-17 |
| 2365988 | CA 2018 00006 | Denmark | ⤷ Subscribe | PRODUCT NAME: PATIROMER SORBITEX CALCIUM AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179/001-009 20170721 |
| 1280520 | C300722 | Netherlands | ⤷ Subscribe | PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
